Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 397-408 of 1,136
Drug study icon
CompletedNCT05550532

Aticaprant 10 Milligrams (mg) for Depression

This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.

In Canada
DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT05328297

JNJ-55308942 for depression in bipolarity

This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.

In Canada
Bipolarity, DepressionDrugFrom 18 Years to 64 Years
Countries
United States, Canada, Poland, ...
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.